MyFinsight
Home
Blog
About
Short-term marketable
securities
$72,389K
(-2.71%↓ Y/Y)
Cash and cash
equivalents
$19,167K
(-24.55%↓ Y/Y)
Accounts receivable,
prepaid expenses and...
$6,209K
Total current assets
$97,765K
(-6.18%↓ Y/Y)
Marketable securities
$79,065K
(-2.49%↓ Y/Y)
Other assets
$2,199K
(-26.53%↓ Y/Y)
Property and equipment,
net
$664K
(-23.50%↓ Y/Y)
Total assets
$179,693K
(-5.00%↓ Y/Y)
Total liabilities and
stockholders' equity
$179,693K
(-5.00%↓ Y/Y)
Total stockholders'
equity
$124,581K
(-5.43%↓ Y/Y)
Total liabilities
$55,112K
(-4.00%↓ Y/Y)
Accumulated deficit
-$1,009,113K
(-8.11%↓ Y/Y)
Accumulated other
comprehensive (loss) income
-$304K
(-163.07%↓ Y/Y)
Additional paidin capital
$1,133,997K
(6.52%↑ Y/Y)
Total current
liabilities
$28,241K
(5.22%↑ Y/Y)
Deferred income, net of
current portion
$14,309K
(-21.46%↓ Y/Y)
Contingent consideration
$11,300K
(7.62%↑ Y/Y)
Other liabilities
$1,262K
(-31.82%↓ Y/Y)
Common stock, 0.00001
par value...
$1K
(0.00%↑ Y/Y)
Accounts payable
$15,516K
(76.38%↑ Y/Y)
Accrued expenses
$5,959K
(-47.78%↓ Y/Y)
Deferred income
$3,976K
(1.58%↑ Y/Y)
Other current
liabilities
$2,790K
(2.69%↑ Y/Y)
Back
Back
Balance Sheet
Aclaris Therapeutics, Inc. (ACRS)
Aclaris Therapeutics, Inc. (ACRS)
source: myfinsight.com